UK Markets open in 25 mins
NIKKEI 225
26,402.84 -508.36 (-1.89%) HANG SENG
20,160.31 -483.97 (-2.34%) CRUDE OIL
110.32 +0.73 (+0.67%) GOLD FUTURES
1,811.50 -4.40 (-0.24%) DOW
31,490.07 -1,164.52 (-3.57%) BTC-GBP
23,635.50 -689.56 (-2.83%)
Illumina, Inc. (ILMN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 243.22 |
| Open | 239.39 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1000 |
| Day's range | 237.89 - 248.54 |
| 52-week range | 208.35 - 526.00 |
| Volume | |
| Avg. volume | 965,922 |
| Market cap | 37.482B |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | 39.26 |
| EPS (TTM) | 6.11 |
| Earnings date | 25 Apr 2022 - 29 Apr 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 371.38 |
- Zacks
Illumina's (ILMN) GRAIL, Intermountain Healthcare Expand Tie-Up
Illumina (ILMN) subsidiary GRAIL's MCED blood test will be offered along with existing single cancer screenings to advance cancer care delivery through early detection.
- Business Wire
GRAIL and Intermountain Healthcare Expand Partnership to Offer Galleri® Multi-Cancer Early Detection Blood Test to Eligible Patients in Utah
MENLO PARK, Calif. & SALT LAKE CITY, May 17, 2022--Intermountain Healthcare will offer Galleri®, GRAIL's multi-cancer early detection blood test, as a complement to existing single cancer screenings.
- Simply Wall St.
Is Illumina, Inc.'s (NASDAQ:ILMN) Recent Price Movement Underpinned By Its Weak Fundamentals?
With its stock down 31% over the past month, it is easy to disregard Illumina (NASDAQ:ILMN). We, however decided to...
© 2022 Yahoo. All rights reserved.
